Tuesday, 12 March 2019

Cadila Healthcare rises 3% on USFDA approval for drugs to treat high blood pressure

It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.

from Moneycontrol https://ift.tt/2J891Xw

No comments:

Post a Comment